Central Dermatology

St Louis, Missouri 63117-1206

0 studies enrolling now · 18 studies all time

What they study most

Atopic Dermatitis, Chronic Plaque Psoriasis, Hidradenitis Suppurativa, Moderate and Severe Plaque Psoriasis, Plaque Psoriasis, Plaque Type Psoriasis, Plaque-Type Psoriasis, Plaque-type Psoriasis, Psoriasis, Psoriasis Vulgaris, Psoriasis-Type Psoriasis

Studies at this site

• LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris — Completed
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed
• Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis — Completed
• Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy — Completed
• Safety and Tolerability of Repeat Courses of IM Alefacept — Completed
• A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis — Completed
• A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp — Completed
• Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis — Completed
• Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) — Completed
• Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis — Completed
• A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis — Completed
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) — Completed
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira — Completed
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients — Completed
• Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index — Completed
• Cutivate Lotion HPA Axis Pediatric Study — Completed
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification — Stopped early
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis — Completed